Physician profile
Marc Feder
NPI 1255662284
$7,182.04
in general payments reported to CMS, 2019-2025
17 companies · $2,017 in 2025
The $2,017 reported for 2025 was more than what 80% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $176 · 2021: $3,654 · 2022: $105 · 2023: $46.11 · 2024: $963 · 2025: $2,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Consulting Fee: $963 · Food and Beverage: $62.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Consulting Fee | $962.50 |
| Food and Beverage | $62.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clarius Mobile Health Corp. | $6,436.66 | 2021-2025 | |
| Dendreon Pharmaceuticals LLC | $135.72 | 2019-2021 | |
| Pfizer INC. | $113.84 | 2019-2022 | |
| Boston Scientific Corporation | $68.64 | 2019-2021 | |
| Janssen Biotech, INC. | $67.16 | 2019-2022 | |
| Ambu INC. | $61.08 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $55.80 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.12 | 2019-2020 | |
| Astellas Pharma US INC | $35.35 | 2019-2022 | |
| Urogen Pharma, INC. | $34.50 | 2021-2023 | Jelmyto |
| Tolmar Pharmaceuticals, INC. | $27.68 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $20.36 | 2022 | |
| Ferring Pharmaceuticals INC. | $16.70 | 2025 | Adstiladrin |
| Olympus America INC. | $14.93 | 2022 | |
| Janssen Scientific Affairs, LLC | $14.16 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12.84 | 2019 | |
| Medtronic USA, INC. | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Feder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.